Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHE.L Regulatory News (GHE)

  • There is currently no data for GHE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Gresham House Plc

1 Sep 2023 15:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Verition Fund Management LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Gresham House Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

31 August 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

25p Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Cash-settled derivatives:

397,230

1.03

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

397,230

1.03

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

GBp

25p Ordinary

CFD

Increasing a long position

7,230

1,056.00

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

none

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

none

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

1 September 2023

Contact name:

Wayne Lennon

Telephone number*:

+1 (203) 617 4370

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230901333297/en/

Copyright Business Wire 2023

Date   Source Headline
24th Apr 20233:27 pmRNSEBT Share Purchase
20th Apr 20237:00 amRNSProgress Update
14th Apr 20237:00 amRNSPosting of Report and Accounts and Notice of AGM
11th Apr 20235:31 pmRNSEBT Share Purchase
3rd Apr 20235:47 pmRNSEBT Share Purchase
31st Mar 20238:19 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSAnnual Results for the year ended 31 December 2022
21st Mar 20232:11 pmRNS2022 Annual Results - revised publication date
15th Mar 20237:00 amRNSNotice of Results
20th Feb 20232:47 pmRNSEBT Share Purchase
13th Feb 20233:06 pmRNSEBT Share Purchase
6th Feb 20235:42 pmRNSEBT Share Purchase
30th Jan 20233:17 pmRNSEBT Share Purchase
25th Jan 20237:00 amRNSPre-Close Update
23rd Jan 20233:03 pmRNSEBT Share Purchase
20th Jan 20237:00 amRNSProgress Update
16th Jan 20234:50 pmRNSEBT Share Purchase
9th Jan 20232:16 pmRNSEBT Share Purchase
9th Jan 20237:00 amRNSLaunch of Irish forestry fund
29th Dec 20229:16 amRNSEBT Share Purchase
23rd Dec 20228:51 amRNSDirector/PDMR Shareholding
22nd Dec 20227:00 amRNSProgress Update
21st Dec 20222:46 pmRNSIncreased Purchase of Shares by EBT
19th Dec 20223:06 pmRNSEBT Share Purchase
12th Dec 20222:11 pmRNSEBT Share Purchase
29th Nov 20229:31 amRNSEBT Share Purchase
22nd Nov 20229:47 amRNSEBT Share Purchase
22nd Nov 20228:56 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSDirector/PDMR Shareholding
10th Nov 20224:03 pmRNSDirector/PDMR Shareholding
9th Nov 20227:00 amRNSTrading Update and Capital Markets Day
7th Nov 20222:41 pmRNSEBT Share Purchase
17th Oct 20225:07 pmRNSEBT Share Purchase
10th Oct 20224:21 pmRNSEBT Share Purchase
3rd Oct 20226:13 pmRNSEBT Share Purchase
21st Sep 20222:48 pmRNSVesting of 2018 Performance Share Plan awards
15th Sep 20227:00 amRNSInterim results
12th Sep 20224:02 pmRNSEBT Share Purchase
12th Sep 20222:47 pmRNSDirector/PDMR Shareholding
5th Sep 20224:01 pmRNSEBT Share Purchase
31st Aug 20227:00 amRNSNotice of Interim Results
30th Aug 20225:34 pmRNSEBT Share Purchase
22nd Aug 20223:47 pmRNSEBT Share Purchase
16th Aug 20227:00 amRNSEBT Share Purchase
1st Aug 20221:44 pmRNSEBT Share Purchase
25th Jul 20223:05 pmRNSEBT Share Purchase
14th Jul 202212:02 pmRNSIntended Purchase of Shares by EBT
13th Jul 20227:00 amRNSTrading Statement
15th Jun 20222:13 pmRNSNotification of Major Holdings
1st Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.